• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Artificial Organs >Current status of artificial heart (assist/replacement) development in the United States
【24h】

Current status of artificial heart (assist/replacement) development in the United States

机译：美国人造心脏（辅助/替代）发展的现状

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

It was a great honor for me to be invited to the 50th Annual Meeting of the Japanese Society for Artificial Organs in Fukuoka, Japan, which is my home town. I came to the Cleveland Clinic in the United States in 1990 to succeed Ryuji Tominaga, MD, who is now the President of this Society. In the nearly 25 years since then, I have been involved in all the artificial heart development programs at the Cleveland Clinic, including total artificial hearts (TAHs), left, right, and bi-ventricular assist devices (LVADs, RVADs, and BVADs), and pediatric ventricular assist devices. At the Asia & Pacific Symposium of this Annual Meeting, I presented my overview of the current status of artificial heart development in the United States, and this editorial summarizes my presentation.Currently, 5 000 000 Americans have congestive heart failure, with 550 000 new cases each year. The need for heart transplantation or mechanical circulatory support is estimated to be 50 000-100 000 patients per year; however, heart transplantation is performed in only 2000-3000 cases per year.
机译：非常荣幸被邀请参加在我家乡日本福冈举行的第50届日本人工器官学会年会。我1990年来到美国克利夫兰诊所，接任现任本会会长的Toyaga Ryuji博士。从那时起的近25年中，我参与了克利夫兰诊所的所有人造心脏开发计划，包括全部人造心脏（TAH），左，右和双心辅助设备（LVAD，RVAD和BVAD） ，以及儿科心室辅助设备。在本次年会的亚太研讨会上，我概述了美国人造心脏发展的现状，并在社论中总结了我的演讲。目前，有5百万美国人患有充血性心力衰竭，其中55万人患有充血性心力衰竭每年的案件。估计每年需要进行心脏移植或机械循环支持的患者为5万至10万;但是，每年仅进行2000-3000例心脏移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号